Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Plaque morphologic characteristics that affect prevention of stroke by carotid revascularization

Award Number: R01NS147997
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/13/2026
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

Plaque morphologic characteristics that affect prevention of stroke by carotid revascularization - PROJECT SUMMARY/ABSTRACT Disruption of carotid atherosclerotic plaque can cause atheroembolism and ischemic stroke. Treating the plaque with surgery or stenting reduces the long-term risk of atheroembolism but with an upfront risk of causing stroke during the revascularization procedure. Compelling evidence supports a net benefit from revascularization in patients with symptomatic carotid stenosis. However, there is a clinical need to improve selection of patients with asymptomatic high-grade (≥70% luminal reduction) carotid stenosis for endarterectomy or stenting in the context of modern intensive medical management (IMM) of atherosclerosis risk factors. CREST-2 (NCT02089217) is a pair of multicenter, randomized trials of IMM with or without revascularization for preventing stroke in patients with high-grade asymptomatic carotid stenosis. CREST-2 completed enrollment of 2,480 patients. Trial follow-up ends on July 31, 2025. CREST-2 specifies baseline pre-randomization carotid duplex ultrasound (DUS) and annual follow-up studies. DUS studies are performed at a lab trained by the CREST-2 Vascular Imaging Core (VIC). DUS blood flow measurements are used to confirm degree of carotid stenosis. The DUS studies also generate standardized B-mode images depicting carotid plaque. The VIC has archived these images. Using standardized image analysis algorithms on the first 503 trial DUS studies, we have successfully assessed the plaque morphologic characteristics we plan to study in this proposal. We will analyze 2000 baseline CREST-2 DUS images of the randomized artery and evaluate relationships between baseline plaque morphologic traits and periprocedural stroke or death plus subsequent ipsilateral stroke. We will also characterize the effectiveness of IMM in changing DUS plaque morphologic features over time in 500 patients followed longitudinally (1000 arteries total: 500 arteries on the randomized side along with 500 arteries on the contralateral side). The directed approach we propose overcomes difficulties inherent in non-randomized cohort studies, including observer bias and confounding by indication. This proposal will, for the first time in a multicenter randomized trial, determine the clinical utility of assessing morphological traits for selecting asymptomatic patients for revascularization and testing new therapies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $442,086 )
2026	2026	MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION)	4500 SAN PABLO RD S	JACKSONVILLE	FL	32224	DUVAL	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	5/14/2026	NEW	$442,086
														Subtotal = $442,086

Grand Total All Awards = $442,086

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Plaque morphologic characteristics that affect prevention of stroke by carotid revascularization

Award Number: R01NS147997

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/13/2026

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer